Median age at relapse (range) | 70 (58-82) |
---|---|
Initial disease | |
T-Stage | T1: 7 (30.4%) T2: 8 (34.8%) T3: 7 (30.4%) NA: 1 (4.3%) |
Median PSA | 10.38 ng/mL (2.34–57) |
Gleason | 5: 1 (4.3%). 6: 5 (21.7%). 7: 13 (56.5%). 9 :1 (4.3%) NA: 3 (13%) |
Prior RT modality | |
External beam radiotherapy | 19 (83%) |
Brachytherapy | 4 (17%) |
Median dose of EBRT (Gy) (range) | 75.6 (70–75.6) |
Residual treatment urinary or rectal toxicities | Yes : 11 (Grade 1 : 7. Grade 2 : 4) No = 12 |
Median interval from prior RT to salvage (range) | 65 months (28 to 150) |
Relapse | |
Biopsy at relapse | Yes: 19 (83%). No: 4 (17%) |
Unilateral positive biopsies | 9 (47%) |
Bilateral positive biopies | 10 (53%) |
Number of positive biopsies : median (range) | 4 (1–13) |
MRI | Yes: 23 (100%). No 0 (0%) |
Involvment on MRI | Unilateral: 12 (52.2%) Bilateral: 10 (43%) None: 1 (4%) |
Extracapsular invasion on MRI | 11 (47%) |
Choline PET scan | Yes: 21 (91.3%) No: 2 (8.7%) |
Androgen deprivation therapy | Yes: 14 (61%) No: 9 (39.1%) |